RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-4.89%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.16B
AUM Growth
+$1.16B
(-7.7%)
Cap. Flow
+$8.48M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
55.45%
Holding
63
New
12
Increased
17
Reduced
17
Closed
13
Top Buys
| 1 |
Xencor
XNCR
|
$26.2M |
| 2 |
Penumbra
PEN
|
$23.4M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$23.3M |
| 4 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$21.1M |
| 5 |
Puma Biotechnology
PBYI
|
$19.3M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$39.3M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$23.3M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$20.8M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$20.1M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$19.1M |
Sector Composition
| 1 | Healthcare | 95.37% |
| 2 | Financials | 0.92% |
| 3 | Communication Services | 0.62% |
| 4 | Consumer Staples | 0.41% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $146M | 12.59% | 16,618,776 -39,296 | -0.2% | -$345K |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $80.3M | 6.92% | 1,520,904 -260,566 | -15% | -$13.8M |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $72M | 6.2% | 1,620,355 -429,630 | -21% | -$19.1M |
|
|
4
Penumbra
PEN
$10.6B
| $66.4M | 5.72% | 1,040,208 +367,290 | +55% | +$23.4M |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $61.3M | 5.28% | 12,331,130 -420,406 | -3% | -$2.09M |
|
|
ARIA
6
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $47.7M | 4.12% | 3,838,376 +1,699,905 | +79% | +$21.1M |
|
7
Incyte
INCY
$16.5B
| $45.3M | 3.91% | 451,987 -145,651 | -24% | -$14.6M |
|
8
Molina Healthcare
MOH
$9.8B
| $43.7M | 3.77% | 805,546 +27,386 | +4% | +$1.49M |
|
|
GWPH
9
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $40.9M | 3.53% | 366,068 -179,854 | -33% | -$20.1M |
|
|
10
Puma Biotechnology
PBYI
$254M
| $39.6M | 3.41% | 1,290,140 +627,854 | +95% | +$19.3M |
|
11
Atara Biotherapeutics
ATRA
$84.6M
| $37.9M | 3.27% | 2,670,942 +649,325 | +32% | +$9.22M |
|
|
NDRM
12
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $34.7M | 2.99% | 1,560,819 +755,573 | +94% | +$16.8M |
|
13
Prothena Corp
PRTA
$441M
| $32.2M | 2.77% | 653,725 -47,934 | -7% | -$2.36M |
|
14
Agios Pharmaceuticals
AGIO
$2.19B
| $30.8M | 2.66% | 738,451 +551 | +0.1% | +$23K |
|
15
Centene
CNC
$14.3B
| $29.2M | 2.52% | 516,598 +52,521 | +11% | +$2.97M |
|
|
16
Xencor
XNCR
$580M
| $26.2M | 2.26% | +996,100 | New | +$26.2M |
|
|
OXFD
17
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $25.4M | 2.19% | 1,701,049 +269,930 | +19% | +$4.04M |
|
18
Wave Life Sciences
WVE
$1.53B
| $24.9M | 2.15% | 951,712 +249,890 | +36% | +$6.53M |
|
|
ESRX
19
DELISTED
Express Scripts Holding Company
ESRX
| $23.3M | 2.01% | +338,800 | New | +$23.3M |
|
|
NSTG
20
DELISTED
NanoString Technologies, Inc.
NSTG
| $20.9M | 1.8% | 937,957 -299,478 | -24% | -$6.68M |
|
|
ALDR
21
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $19.1M | 1.65% | 920,550 +218,011 | +31% | +$4.53M |
|
|
NVRO
22
DELISTED
NEVRO CORP.
NVRO
| $18.9M | 1.63% | 260,380 +33,113 | +15% | +$2.41M |
|
23
Charles River Laboratories
CRL
$8.04B
| $18.8M | 1.62% | 247,107 +120,001 | +94% | +$9.14M |
|
|
CMRX
24
DELISTED
Chimerix, Inc.
CMRX
| $15.4M | 1.33% | 3,345,959 +131,013 | +4% | +$603K |
|
|
BOLD
25
DELISTED
Audentes Therapeutics, Inc
BOLD
| $15.2M | 1.31% | 832,736 -83,890 | -9% | -$1.53M |
|